Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKendrick Resources Regulatory News (KEN)

Share Price Information for Kendrick Resources (KEN)

Share Price is delayed by 15 minutes
Get Live Data
8.00    0.125 (1.59%)
Bid:
7.50
Ask:
8.50
Spread: 1.00 (13.333%)
Market Cap: £33.75m
KEN Live PriceLast checked at - London Stock Exchange

Intraday Kendrick Resources Share Chart

Funding Update

10 Feb 2026 11:50

RNS Number : 4539S
Kendrick Resources PLC
10 February 2026
 

 

10 February 2026

 

Kendrick Resources PLC

("Kendrick" or the "Company")

Funding update

 

Kendrick Resources Plc (LSE: KEN), the mineral exploration and development company, is pleased to announce that it has

 

i) secured a £337,000 unsecured convertible loan facility (the "Convertible Loan Facility") provided by high net worth individuals, including £37,000 from Colin Bird the Company's Chairman (together, the "Lenders") which is convertible at 0.66804 pence per share (the "Convertible Conversion Price") and repayable by 31 January 2027 (the "Convertible Repayment Date"); and

 

ii) long term shareholder Sanderson Capital Partners Ltd ("SCP") has agreed to;

 

a. extend the maturity date for the £375,000 drawdown under the unsecured convertible loan funding facility announced on 22 April 2024 (the "Sanderson Facility") to 30 June 2027; and

 

b. to advance a further £250,000 under the Facility (the "Additional Loan Tranche") which is convertible at the Convertible Conversion Price and repayable at the Convertible Repayment Date.

 

The participation by a major shareholder, high net worth individuals and Chairman Colin Bird underscores the continued confidence in Kendrick's strategy and long-term growth prospects.

 

The funds raised will fund the advancement of the Company's option agreement over the Bonya rare earths project announced on 21 January 2026, the Blue Fox copper exploration project in Zambia and the Company's working capital requirements.

 

The Convertible Conversion Price is at a 3% discount to 0.68660 pence per share being the 30 day VWAP as at 9 February 2026 the latest practical date prior to the issue of this announcement.

 

Convertible Loan Facility

The Convertible Loan Facility is unsecured, and is convertible at the option of the Lenders or the Company and is interest free. The Convertible Loan Facility is convertible, at the Convertible Conversion price save that if prior to repayment there is a 'Qualifying Financing', being any issue of new shares for cash at less than the Convertible Conversion Price the loan will convert at the price and on the same terms as the relevant 'Qualifying Financing'. The agreement includes customary terms and conditions for a facility of this nature.

 

Related Party Transaction - Convertible Loan Facility

Colin Bird is a director of the Company, so a related party for the purposes of the Disclosure Guidance and Transparency Rules ("DTRs"), the participation by Colin Bird in the Convertible Loan Facility constitutes a 'material related party transaction' for the purposes of DTR 7.3 as it is for more than 5% of the aggregate amount of the Convertible Loan Facility and the Additional Loan Tranche (the "Related Party Transaction"). Colin Bird's participation in the Convertible Loan Facility is on the same terms as the other Lenders and provides additional capital for the group's operations, accordingly the independent directors, being Marytn Churchouse, Alex Borrelli, Kjeld Thygesen and Evan Kirby, consider Colin Bird's participation in the Convertible Loan Facility to be fair and reasonable insofar as the Company's shareholders are concerned. 

 

Sanderson Facility

The terms of the £375,000 drawn down under the pre-existing Sanderson Facility remain the same save that the maturity date has been extended to 30 June 2027. The Additional Loan Tranche terms are as follows: 

 

Repayment and Conversion

Repayment

Unless otherwise converted, the Company must repay the Additional Loan Tranche on 31 January 2027 (the "Repayment Date"). The Company may prepay the whole or part of the Facility on any day prior to the Repayment Date upon giving not less than 14 days' prior written notice to the Lender and paying in cash a prepayment fee of 5% of the amount which the Company prepays in cash before the Repayment Date. SCP can during the 14 days' notice period make an election for all or part of the loan subject to a prepayment notice to be repaid in new ordinary shares ("Shares") in which case the 5% fee shall not apply to that proportion of the loan repaid in Shares.

 

Conversion of Loan Tranche by Lender

SCP may at any time prior to the Repayment Date elect to convert all or part of any drawn down amount into such number of Shares equal to the amount of the Additional Loan Tranche that is to be repaid at the date of the election, divided by the Convertible Conversion price, If prior to repayment of the Additional Loan Tranche there is a 'Qualifying Financing', being any issue of Shares for cash at less than the Convertible Conversion Price, then the Additional Loan Tranche's conversion price will be at the price and on the same terms as the relevant 'Qualifying Financing'

 

Conversion of Loan by the Company

The Company may at any time prior to the Repayment Date elect to convert all or part of Additional Loan Tranche if the Share price exceeds 1.336 pence ("Target Conversion Price") for a period of five or more business days.

 

Interest and Fees

The Additional Loan Tranche is interest free. The Lender shall be paid an arrangement fee of 10% of the amount of the Additional Loan Tranche to be settled by the issue of 2,663,843 Shares ("Facility Fee Shares") credited as fully paid by at an issue price of 0.93849p per Share (being the Five Day VWAP on the date of this announcement) with the Facility Fee Shares to be issued on or before 31 December 2026 or such other date agreed by the parties.

 

The Lender shall be paid a further fee of 2% of the amount of the Additional Loan Tranche which is to be settled by the issue of 532,769 new Shares credited as fully paid by at an issue price of 0.93849p per Share (being the Five Day VWAP on the date of this announcement) ("Drawdown Fee Shares") with the Drawdown Fee Shares to be issued on or before 31 December 2026 or such other date agreed by the parties.

 

Warrants

The Lender shall be issued warrants over Shares ("Warrants") exercisable at any time up until 10 February 2029, with a face value equal to £125,000 and an exercise price of 1.336 pence per share for the drawdown of the Additional Loan Tranche.

 

This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended).

 

For further information, please contact:

Kendrick Resources Plc: Chairman

Tel: +44 2039 616 086

Colin Bird

AlbR Capital Limited

Financial Adviser and Joint Broker

Tel: +44 207 469 0930

David Coffman / Dan Harris

Jon Bellis

Shard Capital Partners LLP

Joint Broker

Tel: +44 207 186 9952

Damon Heath / Isabella Pierre

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRAKKBQDBKDPBD
Date   Source Headline
22nd Apr 20247:00 amRNSFunding Facility
8th Feb 20247:00 amRNSAirijoki Drill Results
7th Feb 20247:00 amRNSEspedalen Update
12th Oct 20237:00 amRNSCompletion of Airijoki Extension Drill program
29th Sep 20237:00 amRNSInterim Results for the Six Months to 30 June 2023
21st Aug 20237:00 amRNSOperational Update
7th Aug 20237:00 amRNSAcquisition of New Licences
27th Jul 20233:42 pmRNSSupplemental Notice of Annual General Meeting
11th Jul 20239:43 amRNSSupplemental Notice of Annual General Meeting
5th Jul 20237:00 amRNSNotice of AGM
24th May 20237:00 amRNSStormyra Final Batch Assay Results
4th May 20237:00 amRNSStormyra Second Batch Assay Results, Maiden Drill
28th Apr 20235:33 pmRNSFinal Results for period to 31 December 2022
28th Apr 20237:00 amRNSTotal Voting Rights
24th Apr 202312:19 pmRNSUpdate on issue of equity to EMX
20th Apr 20231:33 pmRNSExercise of Options and Issue of Equity
20th Apr 20231:13 pmRNSEspedalen Update and Assay Results
29th Mar 20237:00 amRNSAirijoki Project Soil Geochemical Characterisation
24th Mar 202312:11 pmRNSExploration Update
2nd Feb 202311:05 amRNSIssue of Options
31st Jan 20232:23 pmRNSEspedalen Drill Programme and Director Appointment
30th Nov 20227:00 amRNSExploration Update
2nd Nov 20227:00 amRNSAirijoki Vanadium – Copper Project Update
24th Oct 20221:20 pmRNSExploration Update
30th Sep 20229:21 amRNSInterim Results
13th Sep 202212:28 pmRNSOperational Update
7th Sep 20227:00 amRNSAppointment of Special Advisor to the Board
31st Aug 20227:00 amRNSTotal Voting Rights
23rd Aug 202212:10 pmRNSResult of AGM
16th Aug 20227:00 amRNSHolding(s) in Company
12th Aug 20229:47 amRNSExercise of option over Norwegian Projects
29th Jul 202211:00 amRNSNotice of Annual General Meeting
29th Jun 20226:22 pmRNSAnnual Financial Report
16th May 20227:00 amRNSExercise of option over Norwegian Projects
6th May 20227:00 amRNSAdmission to Main Market and Fundraise
19th Jan 20119:01 amRNSResult of EGM/Cancellation of Admission
22nd Dec 20107:00 amRNSProposed Delisting on AIM
13th Sep 20107:00 amRNSHalf Yearly Report
28th Jul 20101:14 pmRNSResult of AGM
13th Jul 20107:00 amRNSLoan Facility
30th Jun 20104:28 pmRNSAnnual Financial Report
21st Jun 20107:00 amRNSIssue of Equity and Update on Contract
11th May 20107:00 amRNSPreliminary Results
8th Apr 20102:43 pmRNSResult of EGM
22nd Mar 20107:00 amRNSUpdate on Singapore Land Transport Contracts
3rd Nov 200911:00 amRNSIssue of Equity
16th Sep 20097:00 amRNSHalf Yearly Report
31st Jul 20091:46 pmRNSResult of AGM
20th May 20099:50 amRNSChange of Nominated Adviser Name
30th Apr 20099:41 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.